Wed, Oct 1, 2014, 7:49 PM EDT - U.S. Markets closed

Recent

% | $
Quotes you view appear here for quick access.

Lpath Inc. Message Board

you are viewing a single comment's thread.

view the rest of the posts
  • ajthedrifter ajthedrifter Dec 12, 2011 10:31 PM Flag

    New Drugs

    Your using an article written in February 2011 as your basis for current FDA trend?
    Check this link to FDA approvals for this year. I believe current year has far surpassed previous in approvals.
    The link will take you to FDA site where you can filter down to the information needed. Great reference tool for any biotech investor.

    http://www.fda.gov/Drugs/NewsEvents/ucm130961.htm

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • harriganrobert@rocketmail.com harriganrobert Dec 13, 2011 1:27 AM Flag

      Positive info here ajthedrifte... Thanks!


      Spotlight on Drug Innovation”: An ongoing update of FDA’s Center for Drug Evaluation and Research's novel drug approvals of calendar year 2011
      The availability of new drugs often means new treatment options for patients, and advances in health care for the American public. For this reason, "innovation" is a key word throughout the pharmaceutical industry and the healthcare community. FDA's Center for Drug Evaluation and Research (CDER) regulates over-the-counter and brand name and generic prescription drugs. In this function, CDER supports innovation and plays a key role in helping to advance new drug development

 
LPTN
3.50-0.02(-0.57%)Oct 1 4:00 PMEDT

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.